Yasin Memari

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

Journal: Nature communications
Published: October 13, 2025

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer.

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer.

Journal: Communications medicine
Published: September 15, 2025

BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia.

BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia.

Journal: Annals of hematology
Published: August 27, 2025

Molecular profiling of the Basal-like intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.

Molecular profiling of the Basal-like intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.

Journal: Genome medicine
Published: May 13, 2025

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 02, 2025

A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

Journal: Nature communications
Published: April 29, 2025

Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis.

Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis.

Journal: The Lancet. Oncology
Published: February 06, 2025

Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition.

Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition.

Journal: Clinical and experimental dermatology
Published: December 04, 2024

Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility.

Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility.

Journal: Nature communications
Published: April 03, 2024

Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.

Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.

Journal: Nature communications
Published: March 16, 2024

A redefined InDel taxonomy provides insights into mutational signatures.

A redefined InDel taxonomy provides insights into mutational signatures.

Journal: Nature genetics
Published: February 14, 2024

The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Journal: Nature genetics
Published: August 21, 2023
Showing 1-12 of 43

Last Updated: 09/26/2026